Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501412PMID: 30000472
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 122795-43-1
Drug Levels and Effects
Summary of Use during Lactation
Gadodiamide releases more free gadolinium than some other gadolinium-containing contrast agents. However, guidelines developed by several North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[1-3] Other agents may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
A mother with neuromyelitis optica was nursing her 38-day-old male infant. Each breastfeeding session was about 15 minutes in every 2 hours. She was given gadodiamide (dose not specified) before an MRI scan. She withheld breastfeeding for 6 to 8 hours after the injection. Her infant experienced no immediate adverse effects.[4]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Gadobenate, Gadobutrol, Gadopentetate, Gadoteridol, Gadoterate
References
- 1.
- Copel J, El-Sayed Y, Heine RP, et al. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130:e210–e216. [PubMed: 28937575]
- 2.
- European Society of Urogenital Radiology. ESUR guidelines on contrast media. 2018;Version 10.0. http://www
.esur-cm.org/index.php/en/ - 3.
- American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2022;Version 2022:106-7. https://www
.acr.org/Clinical-Resources /Contrast-Manual. - 4.
- Acar S, Keskin-Arslan E, Erol-Coskun H, et al. Gadodiamide use during breastfeeding. Reprod Toxicol 2018;80:59-60. [Abstract]. doi: 10.1016/j.reprotox.2018.07.071. [CrossRef]
Substance Identification
Substance Name
Gadodiamide
CAS Registry Number
122795-43-1
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Gadoversetamide.[Drugs and Lactation Database (...]Review Gadoversetamide.. Drugs and Lactation Database (LactMed®). 2006
- Review Gadobenate.[Drugs and Lactation Database (...]Review Gadobenate.. Drugs and Lactation Database (LactMed®). 2006
- Review Gadoxetate.[Drugs and Lactation Database (...]Review Gadoxetate.. Drugs and Lactation Database (LactMed®). 2006
- Review Gadopentetate.[Drugs and Lactation Database (...]Review Gadopentetate.. Drugs and Lactation Database (LactMed®). 2006
- Review Iodipamide.[Drugs and Lactation Database (...]Review Iodipamide.. Drugs and Lactation Database (LactMed®). 2006
- Gadodiamide - Drugs and Lactation Database (LactMed®)Gadodiamide - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...